C. Segura

发表

Spread of plasmids containing the bla(VIM-1) and bla(CTX-M) genes and the qnr determinant in Enterobacter cloacae, Klebsiella pneumoniae and Klebsiella oxytoca isolates.

P. Coll, F. Alvarez-lerma, J. Horcajada, 2010, The Journal of antimicrobial chemotherapy.

Contribution of β-Lactamases to β-Lactam Susceptibilities of Susceptible and Multidrug-ResistantMycobacterium tuberculosis Clinical Isolates

C. Segura, M. Salvadó, A. Coira, 1998, Antimicrobial Agents and Chemotherapy.

Contribution of beta-lactamases to beta-lactam susceptibilities of susceptible and multidrug-resistant Mycobacterium tuberculosis clinical isolates.

C. Segura, M. Salvadó, A. Coira, 1998, Antimicrobial agents and chemotherapy.

Colistin in the treatment of urinary tract infections caused by extremely drug-resistant Pseudomonas aeruginosa: dose is critical.

J. Li, S. Luque, N. Campillo, 2019, The Journal of infection.

Colistin for the treatment of urinary tract infections caused by extremely drug-resistant Pseudomonas aeruginosa: a call for a dose update

J. Li, S. Luque, N. Campillo, 2020 .

Beta-lactamase activity in mycobacteria other than M. tuberculosis.

C. Segura, M. Salvadó, A. Coira, 1995, Journal of chemotherapy.

Activity of amoxycillin/clavulanate against beta-lactamase-producing Escherichia coli and Klebsiella spp.

C. Segura, R. Reig, C. Roy, 1989, The Journal of antimicrobial chemotherapy.

Impact of an antimicrobial stewardship program on urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli

J. Horcajada, C. Segura, S. Grau, 2018, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

In Vitro Activity of Ceftazidime and Meropenem in Combination with Tobramycin or Ciprofloxacin in A Clone of Multiresistant Pseudomonas Aeruginosa

E. Fusté, M. Viñas, J. Horcajada, 2013 .

ATP Bioluminescence Assay To Evaluate Antibiotic Combinations against Extensively Drug-Resistant (XDR) Pseudomonas aeruginosa

A. Oliver, J. Horcajada, C. Segura, 2022, Microbiology spectrum.

Validation of a colistin plasma concentration breakpoint as a predictor of nephrotoxicity in patients treated with colistin methanesulfonate.

S. Luque, N. Campillo, J. Horcajada, 2016, International journal of antimicrobial agents.

Evaluation of Ceftolozane-Tazobactam in Combination with Meropenem against Pseudomonas aeruginosa Sequence Type 175 in a Hollow-Fiber Infection Model

A. Oliver, P. Ambrose, J. Horcajada, 2018, Antimicrobial Agents and Chemotherapy.

Colistin plus meropenem combination is synergistic in vitro against extensively drug-resistant Pseudomonas aeruginosa, including high-risk clones.

A. Oliver, P. Ambrose, S. Luque, 2019, Journal of global antimicrobial resistance.

Intra- and inter-species spread of carbapenemase genes in a non-hospitalized patient

J. Horcajada, E. Miró, F. Navarro, 2011, European Journal of Clinical Microbiology & Infectious Diseases.

Moisturizing body milk as a reservoir of Burkholderia cepacia: outbreak of nosocomial infection in a multidisciplinary intensive care unit

P. Coll, A. Vázquez, C. Segura, 2008, Critical care.

Infection due to Actinobaculum spp: report of 12 patients in Spain.

J. Sáez-Nieto, J. Horcajada, C. Segura, 2013, The Journal of infection.

SHV-1 β-Lactamase Is Mainly a Chromosomally Encoded Species-Specific Enzyme in Klebsiella pneumoniae

C. Segura, M. Ladona, A. Coira, 2001, Antimicrobial Agents and Chemotherapy.

Carbapenem-resistance mechanisms of multidrug-resistant Pseudomonas aeruginosa.

E. Fusté, T. Vinuesa, M. Viñas, 2013, Journal of medical microbiology.

Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study

S. Luque, J. Horcajada, C. Segura, 2013, BMC Infectious Diseases.

Incidence of strains producing plasmid determined beta-lactamases among carbenicillin resistant Pseudomonas aeruginosa.

A. Foz, C. Segura, R. Reig, 1986, The Journal of antimicrobial chemotherapy.

Plasmid-determined beta-lactamases identified in a group of 204 ampicillin-resistant Enterobacteriaceae.

C. Fuster, A. Foz, C. Segura, 1983, The Journal of antimicrobial chemotherapy.

Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain

A. Oliver, L. Martínez-Martínez, F. Tubau, 2017, Antimicrobial Agents and Chemotherapy.

Impact of colistin plasma levels on the clinical outcome of patients with infections caused by extremely drug-resistant Pseudomonas aeruginosa

S. Luque, N. Campillo, J. Horcajada, 2017, BMC Infectious Diseases.

Staphylococcus aureus infections in haemodialysis patients : pathophysiology and use of nasal mupirocin for prevention.

C. Segura, A. Coira, J. Chaves, 1995 .

Activity of carumonam and aztreonam againstKlebsiella species

A. Foz, C. Segura, R. Reig, 1985, European Journal of Clinical Microbiology.

[Azthreonam stability against Enterobacteriaceae beta-lactamases].

A. Foz, C. Segura, R. Reig, 1984, Medicina clinica.

Complementary activity of mezlocillin and the combination of amoxicillin with clavulanic acid on Enterobacteriaceae

C. Fuster, A. Foz, C. Segura, 2005, Infection.

First Description of blaNDM-7 Carried on an IncX4 Plasmid in Escherichia coli ST679 Isolated in Spain.

P. Coll, P. Espinal, E. Miró, 2018, Microbial drug resistance.

Risk Factors for Mortality among Patients with Pseudomonas aeruginosa Bloodstream Infections: What Is the Influence of XDR Phenotype on Outcomes?

J. Horcajada, C. Segura, H. Knobel, 2020, Journal of clinical medicine.

Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain

A. Oliver, L. Martínez-Martínez, F. Tubau, 2017, Antimicrobial Agents and Chemotherapy.